Patent ID: 11952387
Assignee: KYORIN PHARMACEUTICAL CO., LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 4:
5. The compound, a pharmacologically acceptable salt of the compound, a hydrate of the compound or a hydrate of the salt according to claim 1, wherein in Formula (1),
X represents N;
Q1 represents CH;
Q2 represents CR3;
L represents —SO2—;
R1 represents a C1-C6 alkyl group, wherein the alkyl group is optionally substituted with one or more substituents selected from the group consisting of a halogen atom, a hydroxy group, a C1-C6 alkoxy group, a haloC1-C6 alkyl group, a cyano group, a 3- to 10-membered heterocycloalkyloxy group, —C(O)R9, and —C(O)NR10R11;
R2 represents a methyl group;
R3 represents H;
R4 represents a C1-C6 alkoxy group, a C1-C6 alkyl group, or a haloC1-C6 alkyl group; and
G represents a hydroxyC1-C6 alkyl group, wherein the hydroxyC1-C6 alkyl group is optionally substituted with W1 and W2, wherein W1 and W2 are each independently H or a C1-C6 alkyl group, and W1 and W2 may be joined together to form a ring, and the ring formed by W1 and W2 is optionally substituted with one or more halogen atoms.